KRAS and cancer: IL-6 could prevent growth of lung tumors in the early cancer stage by maintaining lung homeostasis through regulation of lung macrophages and cytotoxic CD-8 T cells with IL-6/STAT3 signaling activation promoted tumor progression with more tumor colonies through induction of cell proliferation regulator cyclin D1 under KRAS oncogenic stress [51].